JPMORGAN CHASE & CO - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 132 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$445,000
-77.9%
73,726
-86.8%
0.00%
Q3 2019$2,014,000
+9.8%
559,312
-18.9%
0.00%
Q2 2019$1,835,000
+9.9%
689,569
+22.2%
0.00%
Q1 2019$1,670,000
+5.8%
564,259
-43.2%
0.00%
Q4 2018$1,578,000
-58.7%
992,714
-4.5%
0.00%
-100.0%
Q3 2018$3,825,000
+39.3%
1,039,438
+7.1%
0.00%0.0%
Q2 2018$2,745,000
-28.5%
970,168
-6.2%
0.00%0.0%
Q1 2018$3,838,000
+15.0%
1,034,633
-10.7%
0.00%0.0%
Q4 2017$3,338,000
+361.7%
1,159,057
+600.4%
0.00%
Q3 2017$723,000
-81.4%
165,476
-80.5%
0.00%
-100.0%
Q2 2017$3,897,000
+67.9%
849,336
+54.0%
0.00%0.0%
Q1 2017$2,321,000
+25.2%
551,344
+22.8%
0.00%
Q4 2016$1,854,000
+76.9%
448,970
+247.0%
0.00%
Q3 2016$1,048,000
-81.7%
129,379
-82.4%
0.00%
-100.0%
Q2 2016$5,726,000
-30.2%
734,239
-30.9%
0.00%
-50.0%
Q1 2016$8,206,000
-31.3%
1,062,755
-4.0%
0.00%
-33.3%
Q4 2015$11,944,000
+54.2%
1,106,973
-1.3%
0.00%
+50.0%
Q3 2015$7,747,000
-22.0%
1,121,293
+0.0%
0.00%0.0%
Q2 2015$9,933,000
+58.2%
1,121,047
+76.1%
0.00%
+100.0%
Q1 2015$6,279,000
+49.5%
636,771
+85.7%
0.00%0.0%
Q4 2014$4,201,000
+358.6%
342,942
+273.4%
0.00%
Q3 2014$916,000
+510.7%
91,838
+84.9%
0.00%
Q3 2013$150,000
-93.7%
49,669
-82.8%
0.00%
-100.0%
Q2 2013$2,363,000288,8650.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$56,305,0007.98%
BVF INC/IL 2,423,300$10,008,0002.01%
EMORY UNIVERSITY 454,102$1,875,0001.85%
DAFNA Capital Management LLC 196,500$812,0000.71%
Orbimed Advisors 13,107,200$54,133,0000.69%
RTW INVESTMENTS, LP 286,285$1,182,0000.44%
Marcus Capital, LLC 100,000$413,0000.44%
Rock Springs Capital Management LP 1,375,000$5,679,0000.38%
Spark Investment Management LLC 978,600$4,041,0000.33%
Bellevue Group AG 240,000$991,0000.20%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders